The first quarter of 2026 produced a private equity market at war with itself. At the very top — deals above $10 billion — activity hit records. At the middle — deals below $1 billion — volume fell to the lowest levels in years. Total deal count came in at 614 globally, down 22% from Q1 2025’s 785. Aggregate value rose 12.6% to $154.6 billion.
The divergence is wide enough to qualify as a structural shift rather than a cyclical dip.
Twenty-Two Deals Above Ten Billion: A Record
Reuters and LSEG tallied 22 PE-adjacent transactions above the $10 billion threshold in Q1 2026 — more than in any other quarter on record. AI infrastructure drew the highest concentration of large capital, with the OpenAI and Anthropic equity rounds anchoring the list. Large software buyouts and industrial carveouts filled the remaining slots, each backed by one of the handful of global megafund sponsors with the access and capital to participate at that size.
Six of the eight largest PE sponsors by AUM grew committed capital in the quarter. Their deal pace slowed by count but accelerated by dollars — precisely the pattern you would expect from firms optimizing for capital efficiency when deal availability at their natural size range is actually healthy.
Why Mid-Market Volume Has Collapsed
Below the megafund tier, conditions are harder. Mid-market sponsors — those targeting deal sizes from $100 million to $1 billion — are navigating a three-way squeeze: expensive debt, cautious LPs, and stubborn sellers.
On debt: broadly syndicated loan spreads remain elevated relative to the 2019–2021 period. Sponsors underwriting mid-market LBOs at current rates must either pay less or underwrite more growth. Most sellers are offering neither. Linklaters partner Florent Mazeron, commenting in April, described the bid-ask spread as the widest in three years. That gap does not close when neither side needs the transaction more than the other.
On LPs: smaller institutional investors — regional pension funds, insurance general accounts, sub-$5 billion endowments — have reduced private markets allocations through 2025 and into 2026. New fund formation among mid-market sponsors has slowed, constraining dry powder and raising the effective cost of deployed capital.
On sellers: assets acquired at 2020–2022 valuations carry book values that current buyers cannot reach without destroying returns. Sellers who are not forced to transact will wait for conditions that may not arrive soon.
Strategic Urgency as the Only Deal-Closer
The transactions that did close at mid-market sizes in Q1 shared a common thread: one party had a reason not to wait. Corporate sellers with near-term earnings pressure, PE sponsors approaching the end of investment periods, and technology companies facing competitive windows in AI all provided the urgency that pure financial logic was not supplying. That pattern will likely define Q2 dealmaking as well.
The H2 Scenarios
Rate clarity from the Federal Reserve — which split its April 24 vote on H2 cuts — would have the most direct impact on underwriting. M&A advisors estimate that a single decisive cut would pull 50 to 75 deferred transactions back into active processes within 90 days. Five PE-backed IPOs pricing above range in Q1 provides a secondary positive signal, and the May–June calendar will test whether that momentum holds. A strong exit quarter would support a volume recovery beginning in Q3 2026.
Source: Q1 Private Equity Deal Volume Falls 22% Year on Year, Aggregate Value Climbs
